SHB 1129
In CommitteeHouse
Fertility-related services
Concerning health plan coverage of fertility-related services.
This status may be delayed. See Action History below for the latest updates.
How does a bill become law?
- Introduced: The bill is filed and assigned a number.
- Committee: A subject-matter committee holds hearings, takes public testimony, and decides whether to advance the bill.
- Floor Vote: The full chamber (House or Senate) debates and votes on the bill.
- Opposite Chamber: The bill repeats the committee and floor vote process in the other chamber.
- Governor: The Governor reviews the bill and decides whether to sign or veto it.
- Signed: The bill has been signed into law.
AI Analysis
This bill requires most group health plans and state employee health plans to cover infertility diagnosis and treatment—including up to two egg retrievals—and fertility preservation services, starting in 2026 and 2027 respectively. It also requires Medicaid to cover fertility preservation. The goal is to reduce disparities in access to care, especially for LGBTQ+ people, racial/ethnic minorities, and single individuals.
- Starting January 1, 2026, group health plans and state employee health plans must cover standard fertility preservation services—such as egg, sperm, or embryo freezing—for people facing medical treatments (like chemotherapy) that could harm fertility.
- Starting January 1, 2027, group health plans and state employee health plans must cover diagnosis and treatment of infertility, including up to two oocyte (egg) retrievals with unlimited embryo transfers, following medical guidelines.
- Coverage must be provided to spouses and non-spouse dependents, and must match the level of coverage for other pregnancy-related services (e.g., no higher copays or stricter limits).
- Insurers and plans cannot impose extra restrictions on fertility medications, services for third-party reproduction (e.g., surrogacy), or apply separate deductibles/copays—unless those same restrictions apply to all similar medical services.
- Medicaid (Apple Health) must cover fertility preservation services, but not infertility treatment, and cannot apply extra restrictions on fertility drugs or benefit limits.
Who is affected
- State and local government employees and their dependents — Employees of state and local governments who receive health coverage through the Washington State Health Benefits Exchange or similar plans will gain access to infertility diagnosis, treatment, and fertility preservation services starting in 2026 and 2027, respectively.
- Employees with employer-sponsored group health plans — Workers whose employers offer group health plans will see new requirements for coverage of infertility services and fertility preservation starting in 2026 and 2027, depending on plan renewal dates.
- Medicaid (Apple Health) enrollees — Medicaid (Apple Health) enrollees will gain access to fertility preservation services starting in 2026, but not infertility treatment, as the law only requires coverage of preservation for Medicaid.
- People seeking infertility care or fertility preservation — Individuals and couples experiencing infertility—including those who are single, LGBTQ+, or from racial/ethnic minority groups—may see improved access and reduced disparities in care due to standardized coverage.
Pro/Con Analysis
Stronger case for concerns
Potential Benefits (3)
The bill may increase premiums and administrative costs for employers and insurers, which could be passed on to employees through higher premiums or reduced wages—though the legislature notes potential long-term savings from improved health outcomes. However, the cost impact is likely modest given the limited scope (only two egg retrievals) and the fact that many large employers already offer some fertility coverage.
FinancialRef: Fiscal Impact sectionProhibiting separate restrictions on fertility medications could increase utilization and short-term drug costs, but aligns with standard prescription coverage practices—no net cost shift beyond typical formulary management. The bill does not mandate coverage of experimental or non-standard treatments, limiting fiscal risk.
HealthcareRef: Sec. 2(4)(a), Sec. 3(4)(a), Sec. 4(2)(a)Limiting fertility preservation to “standard” services defined by professional guidelines (ASRM, ASCO) prevents coverage of high-cost, unproven, or experimental interventions—keeping costs contained while ensuring evidence-based care. This avoids open-ended liability for insurers.
HealthcareRef: Sec. 2(5)(d), Sec. 3(5)(d)
Potential Concerns (5)
The bill expands coverage to include infertility diagnosis and treatment (up to two egg retrievals) and fertility preservation, which improves access to medically necessary care for people facing infertility—especially single individuals, LGBTQ+ people, and racial/ethnic minorities who face higher out-of-pocket costs and barriers to care. This reduces disparities and aligns coverage with other reproductive health services, promoting equity in access.
HealthcarePeopleRef: Sec. 2(1), Sec. 3(1), Sec. 4(1)Prohibiting separate deductibles, copays, or benefit limits for infertility services ensures parity with other medical services, preventing cost-shifting that disproportionately burdens low- and middle-income patients who may already struggle to afford fertility care. This reduces financial toxicity and improves affordability for everyday Washingtonians.
HealthcarePeopleRef: Sec. 2(4)(c), Sec. 3(4)(c), Sec. 4(2)(b)Medicaid (Apple Health) coverage for fertility preservation—though not infertility treatment—helps low-income patients undergoing cancer treatment or other high-risk medical interventions preserve future fertility, reducing inequities in access to this critical service for vulnerable populations.
HealthcarePeopleRef: Sec. 4(1)Mandating coverage for up to two egg retrievals with unlimited embryo transfers (per ASRM guidelines) and allowing coverage for non-spouse dependents expands access to care for diverse family structures—including single parents, same-sex couples, and adoptive families—reducing discrimination in reproductive healthcare access.
HealthcarePeopleRef: Sec. 2(2), Sec. 3(2)Defining infertility to include inability to reproduce as a single person or with a partner without medical intervention explicitly includes LGBTQ+ individuals and single people, addressing historical exclusion from infertility coverage and reducing systemic bias in healthcare eligibility criteria.
HealthcareLean peopleRef: Sec. 2(5)(b), Sec. 3(5)(b)
Who Is Most Affected
Employees with employer-sponsored plans—especially those at small and mid-sized firms—may gain access to previously unavailable coverage, but could face modest premium increases. However, most large employers already offer some fertility coverage, so the net impact is likely positive for access and equity.
Medicaid enrollees gain fertility preservation coverage (e.g., for cancer patients), but not infertility treatment—limiting the scope of benefit. This is a meaningful expansion for a high-need, low-income population, though less comprehensive than coverage for privately insured individuals.
LGBTQ+ individuals, single people, and racial/ethnic minorities—who face disproportionate barriers to fertility care—benefit significantly from the expanded, equitable coverage and inclusive definitions. This directly addresses documented disparities in access.
State and local government employees and their families gain comprehensive coverage starting in 2026/2027, improving access to care. Premium impacts are minimal since the state already negotiates group rates and many plans already include fertility benefits.
Insurers and employers may face modest administrative costs and premium increases, but the scope is limited (only two egg retrievals, standard services only), and many already cover some fertility services. The bill does not impose sweeping new obligations beyond current industry norms.